Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Entinostat
Syndax Pharmaceuticals
Drug Interaction
1 trial -
Entinostat
Syndax Pharmaceuticals
Neoplasms
2 trials -
Entinostat
Syndax Pharmaceuticals
Volunteers
2 trials -
Entinostat
Syndax Pharmaceuticals
Pancreas Cancer
1 trial -
Entinostat
Syndax Pharmaceuticals
Metastatic Breast Cancer
1 trial -
Epidiolex 100 mg/mL Oral Solution
Jazz Pharmaceuticals Ireland Limited
Electrical Status Epilepticus of Slow-Wave Sleep
1 trial -
Eplontersen
IONIS PHARMACEUTICALS INC
Healthy Participants
1 trial -
Erwinase
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia
1 trial -
Erwinia Chrysanthemi asparaginase
Jazz Pharmaceuticals Ireland Limited
Acute Lymphoblastic Leukemia (ALL)
1 trial -
Erythromycin lactobionate
ADIAL PHARMACEUTICALS, INC.
Diabetes Mellitus, Type 1
1 trial -
Estradiol/Norethindrone acetate
Teva Pharma GmbH
Healthy
2 trials -
Ethinyl Estradioll/Levonorgestrel (EE/LNG)
Atea Pharmaceuticals
Healthy Volunteer Study
1 trial -
Etripamil Nasal Spray 70mg
Milestone Pharmaceuticals
Healthy Chinese Subjects
1 trial -
Evaluation of AG-181 in Subjects 18 to 69 Years of Age With Phenylketonuria
Lacuna Pharma Pty Ltd
Phenylketonuria
1 trial -
Evaluation of bioequivalence of two products containing 400 mg ibuprofen and 100 mg caffeine: Ibuprofen / Caffeine 400 mg / 100 mg coated granules (Test) vs. Thomapyrin TENSION DUO, 400mg / 100mg Filmtabletten (Reference). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 50 mg dimenhydrinate: Dimenhydrinate 50 mg (Test) vs. Vomex A 50 mg Lösung zum Einnehmen im Beutel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of bioequivalence of two products containing 600 mg ibuprofen: Ibuprofen Sopharma 600 mg film-coated tablets (Test) vs. Brufen 600 mg film-coated tablets (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy volunteers
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of the Effect of Food, Itraconazole, and Rifampicin on the Single-Dose Pharmacokinetics of Naronapride.
Dr. Falk Pharma GmbH
No medical condition.
1 trial -
Evaluation of the Effect of Itraconazole, Quinidine and Rifampicin on the Single-Dose Pharmacokinetics of ZED1227
Dr. Falk Pharma GmbH
No medical condition.
1 trial -
Evaluation of the bioavailability of two transdermal gel preparations containing 0.1% w/w estradiol under fasting conditions: Estradiol/INTERMED gel 0.1% w/w (Test) vs. ESTREVA® 0.1%, gel (Comparator). A monocentric, open, randomized, single dose, two-period, crossover trial in healthy postmenopausal women
Lacuna Pharma Pty Ltd
No therapeutic indication in the current trial with healthy volunteers.
1 trial -
Evaluation of the effect of CHF6795 on the pharmacokinetics of midazolam, repaglinide and rosuvastatin in healthy subjects
Chiesi Farmaceutici S.p.A
Chronic cough
1 trial -
Evaluation of vamorolone CYP3A4 induction on midazolam (a sensitive CYP3A4 substrate) pharmacokinetics
Lacuna Pharma Pty Ltd
Phase I study in healthy male volunteers. Intended indication: Duchenne muscular dystrophy and Becker muscular dystrophy
1 trial -
Exploratory study to assess the pharmacokinetic interaction of doxepin with adrenaline after a concomitant co-administration using the Anapen® device and to compare the adrenaline comparative bioavailability with Anapen®500 commercial form in healthy normal weight male subjects
Bioprojet Pharma
Anaphylaxis
1 trial -
FVH1 - a DNA-based influenza vaccine
INOVIO PHARMACEUTICALS, INC.
Influenza, Human
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources